OncoProt Overview
- Headquarters
- Fr
- Website
- www.tbmcore.cnrs.fr
- Industry
- Research Services
- Employees
- 6
- Founded
- 2017
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Keywords
About OncoProt
The OncoProt platform offers to combine laser microdissection and mass spectrometry to study the proteome of all types of oncological cellular or tissue structures Microdissection makes it possible to isolate a particular population of cells or a cellular region of interest using laser cutting, from specimens fixed in formalin and embedded in paraffin. The proteins are then extracted after reversal of the binding, and are analyzed by mass spectrometry to identify and quantify them. By proteomic profiling, we can use all the deregulated proteins as an identity card for a pathology, which makes it possible to define reference profiles with diagnostic, prognostic value or response to treatments. Thanks to dedicated bioinformatics and integrative biology tools and the intervention of the bioinformatician of our team, we can be of support in the biological interpretation of proteomics data and in the graphical representation of your results.
Compare Similar Companies to OncoProt
Macquarie Group
Financial Services
KNAUER
Biotechnology
DIXI medical
Medical Equipment Manufacturing
BRIC-BoRdeaux Institute of onCology
Research
Coave Therapeutics
Biotechnology Research
IReSP - Institut pour la Recherche en Santé Publique
Research Services
TBMCore
Research Services
BeLiver
Biotechnology Research
SÆPTUM
Medical Equipment Manufacturing
PHARMAnetwork
Pharmaceutical Manufacturing